A virus that has so far killed nearly thirty people in seven countries faces a non-medical obstacle to treatment: Patents. Reader Presto Vivace writes with this excerpt from the Council on Foreign Relations: "At the center of the dispute is a Dutch laboratory that claims all rights to the genetic sequence of the Middle East Respiratory Syndrome coronavirus [MERS-CoV]. Saudi Arabia's deputy health minister, Ziad Memish, told the WHO meeting that "someone"--a reference to Egyptian virologist Ali Zaki--mailed a sample of the new SARS-like virus out of his country without government consent in June 2012, giving it to Dutch virologist Ron Fouchier of Erasmus Medical Center in Rotterdam."

redletterdave writes "In trying to solve the 'mechanical mismatch' between humans and electronics — particularly wearables — special projects chief Regina Dugan unveiled two new projects currently in development at Google's Motorola Mobility centered on rethinking authentication methodology, including electronic tattoos and ingestible pills. Of the pill, which Dugan called her 'first superpower,' she described it as an 'inside-out potato battery' that when swallowed, the acids in one's stomach serve as the electrolyte to power an 18-bit ECG-like signal that essentially turns one's body into an authentication token. 'It means my arms are like wires and my hands are like alligator clips [so] when I touch my phone, my computer, my door, I'm authenticated,' Dugan said. 'This is not science fiction.'"

schwit1 writes "Parents in Polk County, Florida are outraged after learning that students in area schools had their irises scanned as part of a new security program without obtaining proper permission. Two days before their Memorial Day weekend break, kids from at least three different public schools — Bethune Academy (K–5), Davenport School of the Arts (K–5, middle, and high school), and Daniel Jenkins Academy (grades 6–12) — were subjected to iris scans without their parents' knowledge or consent. The scans are essentially optical fingerprints, which the school intended to collect to create a database of biometric information for school-bus security."

cylonlover writes "Science fiction may well become reality with the development of a real life Iron Man suit that would allow astronauts or extreme thrill seekers to space dive from up to 62 miles (100 km) above the Earth's surface at the very edge of space, and safely land using thruster boots instead of a parachute. Hi-tech inventors over at Solar System Express (Sol-X) and biotech designers Juxtopia LLC (JLLC) are collaborating on this project with a goal of releasing a production model of such a suit by 2016. The project will use a commercial space suit to which will be added augmented reality (AR) goggles, jet packs, power gloves and movement gyros."

sciencehabit writes "In 2009, a global collaboration of scientists, public health agencies, and companies raced to make a vaccine against a pandemic influenza virus, but most of it wasn't ready until the pandemic had peaked. Now, researchers have come up with an alternative, faster strategy for when a pandemic influenza virus surfaces: Just squirt genes for the protective antibodies into people's noses. The method—which borrows ideas from both gene therapy and vaccination, but is neither—protects mice against a wide range of flu viruses in a new study."

westtxfun writes "'Russian scientists claimed Wednesday they have discovered blood in the carcass of a woolly mammoth, adding that the rare find could boost their chances of cloning the prehistoric animal.' As scientists unearthed the recent find, very dark blood flowed out from beneath the mammoth, and the muscle tissue was red. This is the best-preserved specimen found so far and they are hopeful they can recover DNA and clone a mammoth. Semyon Grigoriev, one of the researchers, said, 'The approximate age of this animal is about 10,000 years old. It has been preserved thanks to the special conditions, due to the fact that it did not defrost and then freeze again. We suppose that the mammoth fell into water or got bogged down in a swamp, could not free herself and died. Due to this fact the lower part of the body, including the lower jaw, and tongue tissue, was preserved very well. The upper torso and two legs, which were in the soil, were gnawed by prehistoric and modern predators and almost did not survive.'"

First time accepted submitter ben saad issam writes in with news about a new biological transducer built by Israeli scientist. "Using only biomolecules (such as DNA and enzymes), scientists at the Technion-Israel Institute of Technology have developed and constructed an advanced biological transducer, a computing machine capable of manipulating genetic codes, and using the output as new input for subsequent computations. The breakthrough might someday create new possibilities in biotechnology, including individual gene therapy and cloning."

cyachallenge writes "Scientists say they have, for the first time, cloned human embryos capable of producing embryonic stem cells. 'We had to find the perfect combination,' Mitalipov says. As it turned out, that perfect combination included something surprising: caffeine. That ingredient, plus other tweaks in the process, including using fresh eggs and determining the optimal stage of each egg's development, Mitalipov says."

Dr. Mark Post hopes to bring the dream of cultured meat one step closer to reality when he unveils his high tech hamburger in London. The five ounce burger is composed of 20,000 strips of beef muscle tissue grown in a laboratory at a cost of $325,000 (provided by an anonymous donor.) From the article: "The hamburger, assembled from tiny bits of beef muscle tissue grown in a laboratory and to be cooked and eaten at an event in London, perhaps in a few weeks, is meant to show the world — including potential sources of research funds — that so-called in-Vitro meat, or cultured meat, is a reality."

symbolset writes "Research published yesterday in the journal Cell (abstract) by Richard Lee and Amy Wagers of Harvard has isolated GDF-11 as a negative regulator of age-associated cardiac hypertrophy. 'When the protein ... was injected into old mice, which develop thickened heart walls in a manner similar to aging humans, the hearts were reduced in size and thickness, resembling the healthy hearts of younger mice.' Through a type of transfusion called parabiotic or 'shared circulation' in mice — one old and sick, the other young and well — they managed to reverse this age-associated heart disease. From there, they isolated an active agent, GDF-11, present in the younger mouse but absent in the older, which reverses the condition when administered directly. They are also using the agent to restore other aged/diseased tissues and organs. Human applications are expected within six years. Since the basis for the treatment is ordinary sharing of blood between an older ill, and younger healthy patient, we can probably expect someone to start offering the transfusion treatment somewhere in the world, soon, to those with the means to find a young and healthy volunteer."

HiveBio in Seattle is not the world's first community-based biology lab, but it may be the first one started by a high school student. Her name is Katriona Guthrie-Honea, and her co-founder is Bergen McMurray. They managed to get a lot of equipment and supplies donated to their new venture, along with a successful Microryza Campaign that raised $6425 even though their target was only $5100. They're renting space from a local hackerlab, and getting an insane amount of publicity for a venture that's just starting out. But why not? If Bergen's and Katriona's example can spur others to learn and create, whether in mechanical engineering, physics, electronics, computer science or biology, it's all good -- not only for the participants, but for anyone who might someday benefit from creations or discoveries made by people who got their first taste of hands-on science or engineering in a hackerspace or community biology lab.

kkleiner writes "A team has launched a crowdsourcing campaign to develop sustainable natural lighting by using a genetically modified version of the flowering plant Arabidopsis. Using the luciferase gene, the enzyme responsible for making fireflies glow, the researchers will design, print, and transform the genes into the target plant. The project, which was recently launched on Kickstarter, has already raised over $100k with over a month left to go."

ananyo writes "Two dangerous things together might make a medicine for one of the hardest cancers to treat. In a mouse model of pancreatic cancer, researchers have shown that bacteria can deliver deadly radiation to tumours — exploiting the immune suppression that normally makes the disease so intractable. The researchers coated the bacterium Listeria monocytogenes with radioactive antibodies and injected the bacterium into mice with pancreatic cancer that had spread to multiple sites. After several doses, the mice that had received the radioactive bacteria had 90% fewer metastases compared with mice that had received saline or radiation alone."

hessian writes with a story at Wired (excerpt below) about a project from Drew Endy of the International Open Facility Advancing Biotechnology, or BIOFAB, to standardize a programming language connecting genetic information from DNA to the cell components that DNA can create. "The BIOFAB project is still in the early stages. Endy and the team are creating the most basic of building blocks — the 'grammar' for the language. Their latest achievement, recently reported in the journal Science, has been to create a way of controlling and amplifying the signals sent from the genome to the cell. Endy compares this process to an old fashioned telegraph. 'If you want to send a telegraph from San Francisco to Los Angeles, the signals would get degraded along the wire,' he says. "At some point, you have to have a relay system that would detect the signals before they completely went to noise and then amplify them back up to keep sending them along their way.""

ananyo writes with this bit about lab grown organs from Nature: "Scientists at Massachusetts General Hospital in Boston have fitted rats with kidneys that were grown in a lab from stripped-down kidney scaffolds. When transplanted, these 'bioengineered' organs starting filtering the rodents' blood and making urine. The team, led by organ-regeneration specialist Harald Ott, started with the kidneys of recently deceased rats and used detergent to strip away the cells, leaving behind the underlying scaffold of connective tissues such as the structural components of blood vessels. They then regenerated the organ by seeding this scaffold with two cell types: human umbilical-vein cells to line the blood vessels, and kidney cells from newborn rats to produce the other tissues that make up the organ (paper)."

An anonymous reader writes "Scientists have discovered a way to convert ordinary skin cells into myelinating cells, or brain cells that have been destroyed in patients with multiple sclerosis, cerebral palsy and other myelin disorders. The research, published in the journal Nature Biotechnology, may now enable 'on demand' production of myelinating cells, which insulate and protect neurons to facilitate the delivery of brain impulses to the rest of the body."

An anonymous reader writes "Monday, the Supreme Court will hear a case on the validity of breast cancer gene patents. The court has a chance to end human gene patents after three decades. From the article: 'Since the 1980s, patent lawyers have been claiming pieces of humanity's genetic code. The United States Patent and Trademark Office has granted thousands of gene patents. The Federal Circuit, the court that hears all patent appeals, has consistently ruled such patents are legal. But the judicial winds have been shifting. The Supreme Court has never ruled on the legality of gene patents. And recently, the Supreme Court has grown increasingly skeptical of the Federal Circuit's patent-friendly jurisprudence. Meanwhile, a growing number of researchers, health care providers, and public interest groups have raised concerns about the harms of gene patents. The American Civil Liberties Union estimates that more than 40 percent of genes are now patented. Those patents have created "patent thickets" that make it difficult for scientists to do genetic research and commercialize their results. Monopolies on genetic testing have raised prices and reduced patient options.'"

Lasrick writes "Derrin Culp of the National Center for Disease Preparedness explores the different levels of scrutiny that scientists in microbiology undergo, when compared to those who work in the nuclear weapons field. His complaint is that, even though America's most notorious biosecurity breach — the 2001 anthrax mailings — was the work of an insider, expert panels have concluded that there is no need for intrusive monitoring of microbiologists engaged in unclassified research."

carmendrahl writes "3-D printers don't build only solid objects anymore. They also build liquid objects, thanks to a research team at the University of Oxford. The group custom crafted a 3-D printer to squirt tiny liquid droplets from its nozzles. The 3-D patterned droplets can mimic biological tissues, such as nerve fibers, and may have potential in tissue engineering applications. An expert not involved with the study is cautious about endorsing the tissue engineering applications because they're not yet demonstrated, but praises the team for extending 3-D printing to new classes of materials."

Last week you had a chance to ask co-founder and CEO of Intellectual Ventures, Nathan Myhrvold, questions before his live Q&A. Below you'll find his answers to a few of the highest rated. Make sure you come back today from 12-12:30pm PDT (3-3:30pm ET, 19:00-19:30 GMT) to ask him whatever you like in real time. We'll have a new story for your questions at that time.